Compare · LBGJ vs TMO
LBGJ vs TMO
Side-by-side comparison of Li Bang International Corporation (LBGJ) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LBGJ and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $262.22B, about 229253.9x LBGJ ($1.1M).
- TMO has hit the wire 6 times in the past 4 weeks while LBGJ has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 0 for LBGJ).
- Company
- Li Bang International Corporation
- Thermo Fisher Scientific Inc
- Price
- -
- -
- Market cap
- $1.1M
- $262.22B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2024
- News (4w)
- 0
- 6
- Recent ratings
- 0
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest LBGJ
- SEC Form 6-K filed by Li Bang International Corporation Inc.
- SEC Form 6-K filed by Li Bang International Corporation Inc.
- Li Bang International Corporation Inc. Announces Results of September 2026 Extraordinary General Meeting
- LI BANG INTERNATIONAL CORPORATION INC. Announces Adjournment of Extraordinary General Meeting
- SEC Form 6-K filed by Li Bang International Corporation Inc.
- Director Li Funa bought $51,299 worth of Class B ordinary shares (15,088 units at $3.40) (SEC Form 4)
- Chief Executive Officer Huang Feng bought $248,700 worth of Class B ordinary shares (73,147 units at $3.40) (SEC Form 4)
- SEC Form 6-K filed by Li Bang International Corporation Inc.
- SEC Form 6-K filed by Li Bang International Corporation Inc.
- Large owner Hrt Financial Lp sold $30,413 worth of shares (1,086,186 units at $0.03), decreasing direct ownership by 88% to 148,795 units (SEC Form 4)
Latest TMO
- SEC Form 4 filed by Thermo Fisher Scientific Inc
- Sr. VP and Chief HR Officer Britt Lisa P. sold $1,999,960 worth of shares (2,831 units at $706.45) (SEC Form 4)
- SEC Form 8-K filed by Thermo Fisher Scientific Inc
- SEC Form 10-Q filed by Thermo Fisher Scientific Inc
- SEC Form 8-K filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Reports Third Quarter 2026 Results
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M